Game Day to Support Boston Children’s Hospital for a Day of Fun

November 5, 2020

Game Day, is a virtual gaming event that will bring together families and gamers alike for a day of fun and fundraising. Boston Children’s Hospital is working with Extra Life to host Game Day.

On Saturday, November 7, participants will be encouraged to gather family or friends virtually to play anything from their favorite board game to online video games – all in the spirit of raising funds to support patient care and lifesaving research at Boston Children’s, the nation’s top pediatric hospital. Participants can also follow along with other gamers as games are streamed on Twitch.

To participate, players will sign-up at extra-life.org and choose Boston Children’s Hospital, play their games and donate what they can to the hospital. Money raised through the event will benefit many areas of Boston Children’s Hospital, through its Every Child Fund. This fund fuels promising research and vital family services not covered by insurance. Every penny raised goes directly to helping kids.

Extra Life unites thousands of gamers around the world in support of local Children’s Miracle Network Hospitals. Since its inception in 2008, Extra Life has raised more than $70 million for sick and injured kids.

“For twenty years, the Extra Life program has been connecting gamers all over the country to support families at Boston Children’s Hospital,” said Erin Keefe, development coordinator, Boston Children’s Hospital Trust. “There are over 1,700 gamers who are committed to Extra Life throughout the year leading up to our big national Game Day in November. Last year alone, our Extra Life program raised over $400K to help patients and families at Boston Children’s.”

 

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.